Tag: pharma stocks

Dr Reddy’s recalls epilepsy drug in US over mislabeling concerns – CNBC TV18

Dr Reddy’s Laboratories has announced a nationwide recall of one batch of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 mL) in the US due to a labeling error on the infusion bag. The recall, which applies to lot number A1540076, was initiated after the infusion bag was incorrectly labeled as Levetiracetam in 0.82% Sodium […]

Stocks to watch on March 3: Auto stocks, NTPC, Ujjivan SFB and more – CNBC TV18

1 / 10 Tata Motors | The Tata Group auto major on Saturday reported an 8% year-on-year decline in its domestic and international sales at 79,344 units in February. The auto major sold 86,406 units in the same month last year. Total domestic sales were 9 per cent down at 77,232 units last month against […]

Biocon launches generic Liraglutide in the UK for diabetes, obesity treatment – CNBC TV18

Biopharmaceutical firm Biocon Ltd announced the launch of its Glucagon-like Peptide-1 (GLP-1) analog, Liraglutide, in the United Kingdom (U.K.). The drug is used for the treatment of diabetes and obesity. This launch follows the nod from the U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA), making Biocon the first generics company to receive approval for […]

USFDA clears Zydus Lifesciences’ Ahmedabad facility with zero observation – CNBC TV18

Zydus Lifesciences Ltd on Friday announced that the United States Food and Drug Administration (USFDA) has completed an inspection at its facility in Ahmedabad with nil observations. Company Value Change %Change The US FDA concluded the inspection today with zero observations, the company announced in a press on Friday. The US health regulator inspected the […]

Wockhardt swings to profit in Q3, reports multifold growth in EBITDA – CNBC TV18

Wockhardt Ltd. swung to a net profit of ₹20 crore in Q3FY25, a sharp recovery from the ₹86 crore loss reported in the same period last year. Company Value Change %Change The pharmaceutical and biotechnology company, which manufactures drugs, vaccines, and other healthcare products, also posted steady revenue growth during the quarter. Revenue rose 3% […]

Cipla to exceed FY25 guidance, sees minimal impact from PEPFAR funding freeze – CNBC TV18

Cipla Ltd. has expressed optimism about exceeding its FY25 guidance, supported by strong operational performance and a focused strategy. Company Value Change %Change The company stated that supply challenges related to Lanreotide, a crucial product, are expected to ease from Q1 FY26, paving the way for improved output and consistent supply. The management also highlighted […]

Top five Pharma stocks to bet on for 2025, according to Motilal Oswal Wealth – CNBC TV18

1 / 8 Brokerage firm Motilal Oswal Wealth Management wrote in a note that India’s Pharma industry is likely to grow between 9% to 11% in financial year 2026, citing a report by CRISIL. The growth will be led by price hikes and new launches in the domestic market and a rise in export demand […]

Granules India subsidiary receives USFDA nod for ADHD treatment drug – CNBC TV18

Granules India Ltd has received approval from the United States Food and Drug Administration (USFDA) for Lisdexamfetamine Dimesylate chewable tablets, used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Company Value Change %Change The pharmaceutical company, in an exchange filing on Tuesday, said its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has been granted […]

Sensex Today | Stock Market LIVE Updates: Nifty looks to sustain its breakout and reclaim 24,750

Sensex Today | Stock Market LIVE Updates: Indian benchmark indices Nifty 50 and Sensex ended the previous trade session in the red. Nifty 50 closed at 24,677.80, while Sensex ended at 81,709.12. Sensex Today | Stock Market LIVE Updates: Nifty 50 ended the previous trade session 1,599.55 points away from its record high of 26,277.35. […]

Back To Top
Translate »